- OREX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $20.5 million.
- OREX traded 298,411 shares today in the pre-market hours as of 8:16 AM, representing 10.2% of its average daily volume.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in OREX with the Ticky from Trade-Ideas. See the FREE profile for OREX NOW at Trade-Ideas More details on OREX: Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Currently there are 4 analysts that rate Orexigen Therapeutics a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Orexigen Therapeutics has been 3.7 million shares per day over the past 30 days. Orexigen has a market cap of $728.5 million and is part of the health care sector and drugs industry. The stock has a beta of 3.87 and a short float of 39.9% with 12.48 days to cover. Shares are up 13.3% year-to-date as of the close of trading on Wednesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.